SW

Steven Wang

VC Partner, Partner and Senior Managing Director at Orbimed

Location

China, Asia

Check Size

$1M - $75M

Investment Stage

Seed
Series A

Focus Areas

Health IT
Health & Hospital Services
BioTech
Pharmaceuticals
Medical Devices

About Investor

Steven Wang is a Partner and Senior Managing Director at OrbiMed in Shanghai, focusing on healthcare equity investments of $1 M–$75 M across medical devices, pharmaceuticals, biotech and health-IT, usually at seed and Series A stages. His most recent investment is Epigenic Therapeutics, a gene-modulation therapy developer. He is based in Shanghai, China. Before OrbiMed (which he joined in 2019), he spent over 15 years in healthcare investment banking at Morgan Stanley, UBS and Rothschild, and began his career as a research scientist in allergy and immunology.

Looking for investors like Steven Wang?
Get matched with the right ones for your startup.

Explore more investors

Previous investments

Epigenic Therapeutics
32M |2023
HanBio Therapeutics
40M |2022

Similar Investors

TN

Tetsu Nakajima

Japan, Asia
$100K - $5M

Pre Seed

,

Seed

,
BT

Binh Tran

Vietnam, Asia
$500K - $2M

Pre Seed

,

Seed

,
SR

Sajid Rahman

Indonesia, Asia
$100K - $1M

Pre Seed

,

Seed

,
KB

Kenneth Ballenegger

Hong Kong, Asia
$25K - $1M

Pre Seed

,

Seed

,
AC

Alan Chan

Hong Kong, Asia
$100K - $5M

Pre Seed

,

Seed

,
JF

Jixun Foo

Singapore, Asia
$250K - $25M

Seed

,

Series A

,

Is this You?

Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors

This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.

Start Matching For Free